No Data
Vaccine Stocks Take a Hit as FDA Official Points to Link Between COVID-19 Vaccines and Rare Heart Condition in Young Men
Director's Bold Move: Major Stock Purchase at Vaxart
Vaxart, Precigen Among Biotech Gainers After Q3 Results
Earnings Call Summary | Vaxart(VXRT.US) Q3 2025 Earnings Conference
Vaxart Extends Cash Runway Into Q2 2027 With Dynavax Partnership and Targets 2026 Data Readouts
Vaxart | 10-Q: Q3 2025 Earnings Report